Albaño, Crispina I.

HRN: 08-71-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2025
CEFTRIAXONE 1G (VIAL)
11/23/2025
11/30/2025
IV
2g
OD
Infected AVF
Checking Initial Appropriateness 
11/23/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/23/2025
11/30/2025
IV
4.5g
Q6H
Septic Shock
Checking Initial Appropriateness 
11/25/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/25/2025
11/30/2025
IV
2.25gms
Q6
Renal Dosing (Sepsis)
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: